Concepedia
Publication | Open Access
Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry
46
Citations
17
References
2017
Year
Page 1